Expertise in
8
conditions

Dannis G. Van Vuurden

Utrecht, UT, NL 
Expertise in
8
conditions
Utrecht, UT, NL 
OverviewLocationsClinical Research

Overview

Dannis Van Vuurden practices in Utrecht, Netherlands. Mr. Van Vuurden is highly rated in 8 conditions, according to our data. His top areas of expertise are Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, Posterior Fossa Tumor, and Brain Tumor.

His clinical research consists of co-authoring 90 peer reviewed articles. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Utrecht, UT, Netherlands
Other Locations
Amsterdam, NH, Netherlands
Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

90 Total Publications

Do we need B7-H3 immunohistochemistry for the inclusion of children with high-grade central nervous system tumors in clinical trials targeting B7-H3?
Do we need B7-H3 immunohistochemistry for the inclusion of children with high-grade central nervous system tumors in clinical trials targeting B7-H3?
Journal: Neuro-oncology
Published: April 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Van Vuurden's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile